https://www.selleckchem.com/products/ly333531.html
Duchenne muscular dystrophy (DMD) is an inherited progressive disorder that causes skeletal and cardiac muscle deterioration with chronic inflammation. Dental pulp stem cells (DPSCs) are attractive candidates for cell-based strategies for DMD because of their immunosuppressive properties. Therefore, we hypothesized that systemic treatment with DPSCs might show therapeutic benefits as an anti-inflammatory therapy. To investigate the potential benefits of DPSC transplantation for DMD, we examined disease progression in a DMD animal model
Like
Comment
Share
